Affecting Drugs | |
---|---|
Drug Name | PubMed Articles (year of publication) |
1-(5-(4-(1H-indol-3-yl)piperidin-1-yl)-2-phenylpentyl)-3-(3,4-dichlorophenyl)urea | |
8-(2-chlorophenyl)-3-methyl-6-oxo-3,4,7,8-tetrahydro-2H,6H-pyrido[2,1-b][1,3,5]thiadiazine-9-carbonitrile | |
Acyloxymethyl ketones | |
Ala-4(i)phe-diazomethyl ketone | |
Ala-4(i)phe-dmk | |
Aza-epoxides | |
Chembl1241101 | |
Chembl514348 | |
Epoxysuccinates | |
Essentiality, suggested target | |
Metabolic network analysis, suggested target | |
Ml4118 | |
Ml4118s | |
N-((S,E)-7-(benzyloxy)-1-(phenylsulfonyl)hept-1-en-3-yl)piperidine-2-carboxamide | |
Sak2 2,3,5,6-tetrafluorophenoxyarylmethyl ketone, dipeptide vinylsulfone, non-peptidic tfpamk | |
Tcmdc-135965 | |
Vinyl sulfone |